Testosterone Through the Decades: What's Normal, What's Not, and What You Can Do

Men's testosterone doesn't fall off a cliff at 40. It doesn't stay flat until 70 and then crash. What actually happens is more gradual and more modifiable than either narrative suggests — and understanding the timeline gives you a practical map for when to pay attention to what.

Here is what the data shows decade by decade, and what levers are actually worth pulling at each stage.

The population-level context: something is wrong beyond normal aging

Before discussing individual decline, a crucial piece of context. Travison et al. (2007) [^travison2007] compared testosterone levels across three age-matched cohorts of men measured in 1987–89, 1995–97, and 2002–04. Testosterone levels fell by approximately 1% per year of birth cohort — meaning a 65-year-old in 2002 had lower testosterone than a 65-year-old did in 1987, holding age constant.

This is not aging. This is a secular, population-wide decline. The magnitude: testosterone levels in 2002 were roughly 15–20% lower than equivalent-age men in the late 1980s.

The proposed causes are consistent with what we know about testosterone's sensitivity to lifestyle factors: increasing obesity rates, sedentary behavior, environmental endocrine disruptors, dietary changes, and sleep disruption. The relevance: the "normal" reference ranges your lab uses include men who are themselves affected by these secular trends. The floor has dropped.

Your 20s: peak and the factors that shape it

Testosterone peaks in late adolescence to early 20s, typically around 18–20, though the exact peak varies. In the 20s, testosterone is at its highest average and is relatively robust against short-term disruptions.

However, the 20s establish habits that determine the trajectory of the following decades. Feldman et al. (2002) [^feldman2002] documented that body composition at younger ages predicts testosterone levels in middle age — the visceral fat laid down in the 20s and 30s carries forward its aromatase burden.

The 20s action items: Not about intervention — about building the habits that make later decades easier. Resistance training as a normal part of life. Maintaining healthy body weight. Establishing consistent sleep as a non-negotiable. These feel low-stakes in the 20s because testosterone is resilient; they feel high-stakes in the 40s because they determine how much cushion you have.

Your 30s: the 1% begins

The decline begins around 30, averaging 1–2% per year of total testosterone. For most men in their 30s, this doesn't cross a symptom threshold — the decline is gradual enough that nothing feels clearly wrong. This is both reassuring and a trap.

The 30s are when lifestyle factors start diverging meaningfully in their hormonal consequences. A man who has gained 15kg of visceral fat by 35 is running significantly higher aromatase activity than his 25-year-old self. A man who has settled into a sedentary job and 6-hour sleep nights has a measurably different hormonal environment than one who maintained training and 8-hour sleep.

The EMAS study (Wu et al., 2010) [^wu2008] established the EMAS criteria for late-onset hypogonadism: three sexual symptoms (reduced libido, reduced morning erections, erectile dysfunction) plus total testosterone below 11 nmol/L (317 ng/dL) or free testosterone below 220 pmol/L. By these criteria, the prevalence is approximately 2% in men aged 40–49 — low in absolute terms, but meaningful in a large population.

The 30s action items:

• Get a baseline testosterone and full hormonal panel at 35. Knowing your baseline value makes future changes interpretable.
• Prioritize sleep and body composition. The 1% annual decline is modifiable — the lifestyle-driven component (aromatase from visceral fat, cortisol from sleep restriction) is on top of the biological floor, not baked into it.
• Don't start supplementing without testing. Zinc, vitamin D, magnesium — any of these may be appropriate, but appropriate only if deficient. Test first.

Your 40s: when symptoms typically appear

The EMAS study documented a steep increase in late-onset hypogonadism prevalence: from ~2% at age 40–49 to ~5.1% at 50–59, and ~9.5% at 60–69, and ~18.4% at 70–79. The 40s represent the inflection point where the cumulative decline starts producing noticeable symptoms in a meaningful minority of men.

The symptoms that tend to appear first are the subtle ones: slightly reduced motivation and drive, modest decline in exercise performance and recovery, early body composition shifts (gaining fat despite similar diet, losing muscle despite similar training), and occasional but not consistent reduction in morning erections.

Perheentupa et al. (2013) [^perheentupa2009] documented that the rate of decline varies substantially between individuals — with lifestyle factors accounting for a significant portion of between-person variability. Men with normal BMI, regular resistance training, adequate sleep, and low chronic stress in their 40s show meaningfully slower decline than the population average.

The 40s action items:

• Retest testosterone every 2–3 years, or any time symptoms develop
• Prioritize visceral fat reduction if body composition has shifted since your 30s — the aromatase effect accelerates with age
• Sleep becomes non-negotiable: the testosterone peak in slow-wave sleep shrinks with age; protecting sleep architecture matters more, not less
• Consider a comprehensive supplement audit: vitamin D deficiency becomes more prevalent with age and the impact of correcting it increases
• If symptoms are present and testosterone has fallen, consult an endocrinologist before considering TRT — rule out reversible causes first

Your 50s and beyond: managing the new baseline

By the 50s, most men are working with a meaningfully lower baseline than their peak. The clinical question shifts from "how do I slow the decline" to "am I below a threshold where function and health are meaningfully affected."

The EMAS criteria distinguish between the 2–3% of men with clinical hypogonadism (both symptoms and biochemically low testosterone) and the much larger group with low-normal testosterone and some symptoms who are in a clinical grey zone. The grey zone is where most decisions about intervention happen, and where reversible lifestyle factors should be exhausted before pharmacological approaches.

At this stage, the most evidence-supported non-pharmacological interventions remain the same as earlier decades, but their effects tend to be larger per unit of effort in men who have let the lifestyle factors slip:

• Fat loss produces larger relative testosterone increases in men who have accumulated visceral fat compared to men already lean
• Sleep correction in men running chronic deficits produces larger absolute testosterone improvements than in men already sleeping adequately
• Resistance training in previously sedentary 50+ men produces clear hormonal adaptations — you are not too old to start

The PSA/prostate checkpoint

Starting around 45, prostate health monitoring deserves parallel attention. Testosterone and prostate health are not adversarial in the way once thought — the "testosterone causes prostate cancer" hypothesis has largely been revised — but the 40s and 50s are when prostate volume changes begin, when PSA screening conversations become relevant, and when urinary symptoms may start to emerge.

The prostate risk assessment quiz and the prostate self-monitoring guide cover this territory in detail.

What the numbers are telling you

A practical framework for interpreting your testosterone results at any age:

Above 600 ng/dL total T, free T adequate: Unlikely to be a hormonal contributor to symptoms. Focus on other explanations.

400–600 ng/dL: Normal middle-aged range. If symptomatic, look at lifestyle factors and free T/SHBG before concluding this is the issue.

300–400 ng/dL with symptoms: Clinical grey zone. Exhausts reversible causes: sleep, body composition, stress, vitamin D, zinc, magnesium. Retests at 3 months.

Below 300 ng/dL confirmed on two morning draws: Clinical hypogonadism by most criteria. Endocrinology referral. Investigate primary vs secondary before discussing TRT.

The supplement stack appropriate for most men in their 40s and beyond:

These are appropriate only in the context of deficiency — test before you supplement, and use these to correct documented deficits rather than as blanket prevention.